A prospective audit of the adherence to a new magnesium sulphate guideline for the neuroprotection of infants born less than 30 weeks' gestation
YH Tan, KM Groom - Australian and New Zealand Journal of …, 2015 - Wiley Online Library
YH Tan, KM Groom
Australian and New Zealand Journal of Obstetrics and Gynaecology, 2015•Wiley Online LibraryAntenatal magnesium sulphate reduces the risk of cerebral palsy in babies born< 30 weeks'
gestation. A guideline for its use in women at imminent risk of preterm birth was
implemented at N ational W omen's H ealth, A uckland C ity H ospital in 2012. This
prospective audit assessed adherence to the guideline in women delivering at< 30 weeks in
the first year after its implementation. Magnesium sulphate was safely administered to 58 of
71 (82%) eligible women and 58 of 61 (95%) of women where it was clinically appropriate …
gestation. A guideline for its use in women at imminent risk of preterm birth was
implemented at N ational W omen's H ealth, A uckland C ity H ospital in 2012. This
prospective audit assessed adherence to the guideline in women delivering at< 30 weeks in
the first year after its implementation. Magnesium sulphate was safely administered to 58 of
71 (82%) eligible women and 58 of 61 (95%) of women where it was clinically appropriate …
Antenatal magnesium sulphate reduces the risk of cerebral palsy in babies born <30 weeks’ gestation. A guideline for its use in women at imminent risk of preterm birth was implemented at National Women's Health, Auckland City Hospital in 2012. This prospective audit assessed adherence to the guideline in women delivering at <30 weeks in the first year after its implementation. Magnesium sulphate was safely administered to 58 of 71 (82%) eligible women and 58 of 61 (95%) of women where it was clinically appropriate and practically achievable.
Wiley Online Library以上显示的是最相近的搜索结果。 查看全部搜索结果